ALPRIM - Medicines
ALPRIM – PRODUCT INFORMATION 5 For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).
Download ALPRIM - Medicines
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
DEPOT PREFILLED DUAL-CHAMBER SYRINGE (PDS) …
www.medicines.org.auLucrin Depot Prefilled Dual-Chamber Syringe (PDS) Injection Version 13 12 May 2015 Page 2 of 18 Lucrin Depot 3-Month PDS Injection is available as sterile lyophilised microspheres, which, when
ELEVA - Medicines
www.medicines.org.auELEVA – PRODUCT INFORMATION 3 During prolonged maintenance therapy for any indication, dosage should be kept at the lowest effective level.
Aratac - Medicines
www.medicines.org.auAratac – Product Information 4 case amiodarone should be withdrawn. Recovery usually occurs within a few months following withdrawal of treatment; clinical recovery precedes the normalisation of thyroid function tests.
Deralin - Medicines
www.medicines.org.auDeralin – Product Information 2 The possible mechanism of the antianginal activity of propranolol hydrochloride appears to be due to a reduction in left ventricular work and oxygen utilisation resulting from inhibition of cardiac sympathetic nerve
AUSTRALIAN PRODUCT INFORMATION ... - …
www.medicines.org.auCABOMETYX Product Information V1.0 4 Safety and efficacy of cabozantinib has not been evaluated in patients with NMYHA Class 3 or 4 Heart Failure and patients with endobronchial manifestations of RCC.
Product Information Zyrtec - Medicines
www.medicines.org.auZyrtec PI Page 1 of 8 Australia J&J Pacific 3rd April 2014 1 of 8 Product Information Zyrtec NAME OF THE MEDICINE Cetirizine hydrochloride DESCRIPTION Cetirizine hydrochloride is an orally active, H
Information, Product, Medicine, Product information zyrtec, Zyrtec, Cetirizine
PRODUCT INFORMATION Axit - Medicines
www.medicines.org.auAxit – Product Information 3 Geriatric. The recommended dosage regimen is the same as for adults. Increases should be monitored carefully (see DOSAGE AND ADMINISTRATION).
PRODUCT INFORMATION CLOFEN - Medicines
www.medicines.org.auCLOFEN – PRODUCT INFORMATION 2 Pharmacokinetics Absorption Baclofen is rapidly and completely absorbed from the gastrointestinal tract. Maximum concentrations of …
Humira Pen - Medicines
www.medicines.org.auHUMIRA 40MG/0.8ML PEN 16 APRIL 2018 VERSION 24 2 pan-uveitis, an inflammatory disease of the uveal tract of the eye. Humira is used in adults who have not
AUSTRALIAN PRODUCT INFORMATION PANADOL …
www.medicines.org.au4 PANADOL CHILDREN 1 to 5 YEARS COLOURFREE SUSPENSION AGE AVERAGE WEIGHT DOSE 1 – 2 years 10 - 12 kg 6 - 8 mL 2 – 3 years 12 - 14 kg 8 - 9 mL
Related documents
chapter 45 Hospital pharmacy management
apps.who.int45 / Hospital pharmacy management 45.3 45.1 Responsibilities of hospital staff The hospital pharmacist should be an expert on medicines who advises on prescribing, administering, and monitoring,
Management, Chapter, Hospital, Medicine, Pharmacy, Chapter 45 hospital pharmacy management
Improving Reassessment and Documentation of Pain …
heilbrunnfamily.rucares.orgThe Joint Commission Journal on Quality and Patient Safety Improving Reassessment and Documentation of Pain Management Performance Improvement M uch has been accomplished in recent years to improve the recognition of inadequate manage-
Management, Documentation, Improving, Improving reassessment and documentation of, Reassessment
Medical gases Health Technical Memorandum 02-01: …
www.bcga.co.ukMedical gases Health Technical Memorandum 02-01: Medical gas pipeline systems Part B: Operational management 9 780113 227433 ISBN 0-11-322743-4 www.tso.co.uk
Health, Management, Medical, Technical, Sage, Memorandum, Medical gases health technical memorandum 02
Stemzine Product Information - Medicines
www.medicines.org.austemzine -ccsiv2-piv13-14aug17 3 Hypothermia Severe hypothermia may occur during swimming in cold water or in patients receiving antipyretic therapy.
Information, Product, Medicine, Stemzine, Stemzine product information
Essential Medicines in Palliative Care - WHO
www.who.intWHO – Essential Medicines in Palliative Care (January 2013) 5 New recommended medicine for addition is used for medicines not listed in the WHO EML New recommended formulation and/or dosage for addition to EML is used when new formulations are recommended which are currently not listed in the EML. Anorexia (appetite loss)
Care, Essential, Medicine, Palliative, Essential medicines in palliative care